Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zachary Jackson

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Endocrinology|May 26, 2022
Excess Growth Hormone Alters the Male Mouse Gut Microbiome in an Age-dependent MannerElizabeth A Jensen, Jonathan A Young, Zachary Jackson, et al.
Leukemia|July 10, 2021
Single cell RNA sequencing of AML initiating cells reveals RNA-based evolution during disease progressionL C Stetson, Dheepa Balasubramanian, Susan Pereira Ribeiro, et al.
Frontiers in Immunology|August 28, 2020
Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of Non-hodgkin LymphomaZachary Jackson, Anne Roe, Ashish Arunkumar Sharma, et al.
Eclinicalmedicine|March 21, 2025
Treatment of non-Hodgkin lymphoma with point-of-care manufactured CAR T cells: a dual institution, phase 1 trialArmin Ghobadi, Paolo F Caimi, Jane S Reese, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Endocrinology|May 26, 2022
Excess Growth Hormone Alters the Male Mouse Gut Microbiome in an Age-dependent MannerElizabeth A Jensen, Jonathan A Young, Zachary Jackson, et al.
Leukemia|July 10, 2021
Single cell RNA sequencing of AML initiating cells reveals RNA-based evolution during disease progressionL C Stetson, Dheepa Balasubramanian, Susan Pereira Ribeiro, et al.
Frontiers in Immunology|August 28, 2020
Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of Non-hodgkin LymphomaZachary Jackson, Anne Roe, Ashish Arunkumar Sharma, et al.
Eclinicalmedicine|March 21, 2025
Treatment of non-Hodgkin lymphoma with point-of-care manufactured CAR T cells: a dual institution, phase 1 trialArmin Ghobadi, Paolo F Caimi, Jane S Reese, et al.
Pageof 3